Maythinee Chantadisai

Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using ¹⁷⁷Lu-FAP-2286: First-in-Humans Results

Richard P. Baum, Christiane Schuchardt, Aviral Singh et al. · Journal of Nuclear Medicine · 2021 · 327 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

MaligNet: Semisupervised Learning for Bone Lesion Instance Segmentation Using Bone Scintigraphy

Terapap Apiparakoon, Nutthaphol Rakratchatakul, Maythinee Chantadisai et al. · IEEE Access · 2020 · 47 citations · Full text

Computing, Computer Science, Radiology +17

Whole-body uptake classification and prostate cancer staging in 68Ga-PSMA-11 PET/CT using dual-tracer learning

Nicolò Capobianco, Ludovic Sibille, Maythinee Chantadisai et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2021 · 42 citations · Full text

Medicine, Nuclear Medicine, Radiology +17

Therapy-related myeloid neoplasm after peptide receptor radionuclide therapy (PRRT) in 1631 patients from our 20 years of experiences: prognostic parameters and overall survival

Maythinee Chantadisai, Harshad Kulkarni, Richard P. Baum · European Journal of Nuclear Medicine and Molecular Imaging · 2020 · 41 citations

Medicine, Nuclear Medicine, Oncology +12

Pretherapeutic Comparative Dosimetry of¹⁷⁷Lu-rhPSMA-7.3 and¹⁷⁷Lu-PSMA I&T in Patients with Metastatic Castration-Resistant Prostate Cancer

Benedikt Feuerecker, Maythinee Chantadisai, Anne Allmann et al. · Journal of Nuclear Medicine · 2021 · 31 citations · Full text

Medicine, Nuclear Medicine, Oncology +17